Evidence map›Paper›PMID 31919664›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

The use of complementary medicine in palliative care in France: an observational cross-sectional study.

Marilene Filbet, Janet Schloss, Jean-Baptiste Maret, Helene Diezel, Per J Palmgren, Amie Steel

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Quality of life in terminally ill cancer patients: what is the role of using complementary and alternative medicines?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  5. Article
  6. Article
  7. Expectation-based medicine in French palliative care centers: is Lyon representative?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  8. Opportunities and challenges associated with health service research of complementary medicine in France: response to Braillon.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  9. Integrative OncologyIntegrative cancer therapies
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Marilene FilbetCentre de Soins Palliatifs, Centre Hospitalier Lyon Sud, Lyon Sud, France.
Janet SchlossOffice of Research, Endeavour College of Natural Health, Brisbane, QLD, Australia.
Jean-Baptiste MaretCentre de Soins Palliatifs, Centre Hospitalier Lyon Sud, Lyon Sud, France.
Helene DiezelOffice of Research, Endeavour College of Natural Health, Brisbane, QLD, Australia.
Per J PalmgrenDepartment of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
Amie SteelOffice of Research, Endeavour College of Natural Health, Brisbane, QLD, Australia. amie.steel@uts.edu.au.ORCID http://orcid.org/0000-0001-6643-9444

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePalliative care for cancer deals with physical, psychosocial, and spiritual issues faced by cancer patients, their families, communities, and healthcare providers. Research on complementary medicine (CM) use in France is limited despite high rates of reported CM use in other countries including by palliative patients. This study describes the use of CM by individuals receiving palliative care in Lyon, France.

designThis study employed an observational cross-sectional survey design. SETTING/

participantsThe study was conducted in three palliative care centers in Lyon, France; two tertiary hospitals and one palliative care unit (3 sites). Inpatients and outpatients visiting the palliative care clinic with a primary diagnosis of cancer at each study site were invited to participate.

resultsOf 138 eligible patients, 100 completed the survey (RR 72.4%). The majority (90.7%) reported using CM in the previous 6 months or since their primary cancer diagnosis. Participant CM use was either the same (20.7%) or increased since their primary cancer diagnosis (33.7%). Average out-of-pocket expenses associated with CM use in the previous 6 months or since diagnosis were €157.40 (SD €330.15). The most common CM health professional visited was an aromatherapist (72.7%), a Coupeurs de feu (38.6%), osteopath (28.6%) and naturopath (15.3%). The most common CM used were aromatherapy oils (33.7%), homeopathy (30.0%), and vitamins (29.4%).

conclusionThis second survey on CM use in France; is the first conducted in palliative care centers. Results show people with cancer in Lyon, France, have a very high prevalence of CM utilization.

Indexed as

Complementary TherapiesCross-Sectional StudiesFemaleFranceHumansMaleMiddle AgedPalliative CarePrevalenceComplementary therapiesFranceHealth servicesPalliative care

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.